Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00129571 · ClinicalTrials.gov registry record · Phase 1
Study of XL820 in Adults With Solid Tumors
A Phase 1 study, sponsored by Exelixis.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00129571: Completed Phase 1 study, sponsored by Exelixis.
NCT00129571 is a Phase 1 study that has completed, run by Exelixis. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00129571, a Phase 1 study, has completed, sponsored by Exelixis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to assess the safety and tolerability of XL820 when given orally to adults with advanced solid tumors.
Interventions
- DRUG XL820
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-08 |
| Phase | Phase 1 |
What the finished NCT00129571 record still lists
NCT00129571 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which XL820 is the first listed.
NCT00129571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00129571 about?
NCT00129571 is a clinical study titled "Study of XL820 in Adults With Solid Tumors". The purpose of this study is to assess the safety and tolerability of XL820 when given orally to adults with advanced solid tumors.
What is the current status of trial NCT00129571?
This trial is currently completed. It is a Phase 1 study. The study started on 2005-08.
What interventions are being tested in trial NCT00129571?
The interventions under investigation include: XL820 (DRUG).
Who is sponsoring clinical trial NCT00129571?
This trial is sponsored by Exelixis, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia